Adverse reactions to levodopa: drug toxicity or progression of disease?
Agid
Y
Y
INSERM U 289 and Féderation de Neurologie-Hôpital de la Salpêtrière, Paris, France.
Chase
T
T
Marsden
D
D
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D007980:Levodopa